IMMUNOSCAPE
Live / Registered — Registered (as of 28 Apr 2020)
What this means for you
Registered since 28 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88035450
- Registration number
- 6039731
- Mark type
- Stylized text
- Filed
- 12 Jul 2018
- Published for opposition
- 11 Feb 2020
- Registered
- 28 Apr 2020
- Attorney of record
- Jon Jekel
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of biotechnology; Research and development services in the field of immune profiling; research and development services in the field of immunotherapy; biotechnology services, namely, probing for multiple T cell specificities identification of tumor antigen-specific T cells for the treatment of cancer; biotechnology services, namely, probing for multiple T cell specificities identification of viral antigen-specific T cells in the field of infectious diseases; biotechnology services, namely, phenotypic and functional T cell and/or other immune cells profiling for use in the field of immunotherapy; biotechnology services, namely, analysis by time-of-flight mass cytometry; research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; biotechnology services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system; consulting services in the field of biotechnology through the application of mass cytometry; Research and development services in the field of vaccines; research and development of immunotherapy products; research and development of vaccines for use in the field of immunotherapy; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; biotechnology services, namely, analysis by flow cytometry; consulting services in the field of vaccine research and development in the field of immunotherapies; platform as a service (PAAS) featuring computer software platforms for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of online non-downloadable computer software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of online non-downloadable computer software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features; providing temporary use of on-line non-downloadable cloud computing software for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of on-line non-downloadable cloud computing software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of on-line non-downloadable cloud computing software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features
Owner
- immunoscape Pte Ltd, Singapore, SG
- immunoscape Pte Ltd, Singapore, SG
- immunoscape Pte Ltd, Singapore, SG
Prosecution history
- 28 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Sept 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 03 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Sept 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Sept 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Sept 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 11 Feb 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Feb 2020 — PUBLISHED FOR OPPOSITION
- 22 Jan 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jan 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Jan 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jan 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE